NewsBenzinga시스타 메디컬, 2026년 ASN 신장 주간에서 발표한 QUELIMMUNE SAVE 레지스트리 분석에서 90일째 생존율 65.1% 기록 시스타 메디컬, 2026년 ASN 신장 주간에서 발표한 QUELIMMUNE SAVE 레지스트리 분석에서 90일째 생존율 65.1% 기록 Benzinga 2026.10.22 16:05 (GMT+0) Open on Benzinga Other news Wolfe Research Initiates Coverage On Abercrombie & Fitch with Outperform Rating, Announces Price Target of $181 Evercore ISI Group Maintains Outperform on Meta Platforms, Raises Price Target to $870 Dow Warns High Interest Rates and Weak Consumer Confidence Are Hurting Housing Demand Evercore ISI Group Maintains Outperform on Knight-Swift, Raises Price Target to $79 Wolfe Research Initiates Coverage On Lululemon Athletica with Underperform Rating, Announces Price Target of $75 Stock of the Day: Where is the Bottom for AT&T?
Wolfe Research Initiates Coverage On Abercrombie & Fitch with Outperform Rating, Announces Price Target of $181
Wolfe Research Initiates Coverage On Lululemon Athletica with Underperform Rating, Announces Price Target of $75
